Antiparasitics are a group of drugs used to treat illnesses caused by parasites like nematodes, cestodes, trematodes, and infectious protozoa.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V52611 | Quinidine-d3 (quinidine d3) | 1267657-68-0 | Quinidine-d3 is the deuterated form of Quinidine. |
|
V54079 | Quinine hemisulfate hydrate (quinine sulfate hydrate) | 207671-44-1 | Quinine hemisulfate hydrate is an alkaloid found in the bark of the cinchona tree and has antimalarial properties. |
|
V54098 | Rafoxanide 13C6 (rafoxanide 13C6) | 1353867-98-7 | Rafoxanide 13C6 is the labeled compound Rafoxanide. |
|
V53274 | Resorantel | 20788-07-2 | Resorantel is an insect repellent. |
|
V54092 | RyRs activator 3 | 2850333-35-4 | RyRs activator 3 (compound A4) is an effective insecticide against the diamondback moth (M. separata) and diamondback moth (P. xylostella). |
|
V76284 | Sahandol | 1452398-07-0 | Sahandol is a diterpene that can be extracted from Salvia sahendica. |
|
V37645 | Salviandulin E | 158994-32-2 | Salviandulin E is a diterpenoid extracted from Salvia mexicana. |
|
V56202 | Secnidazole-d6 (RP-14539-d6; PM-185184-d6) | 1346603-27-7 | Secnidazole-d6 is the deuterated form of Secnidazole. |
|
V36982 | Sesquicillin A | 51103-58-3 | Sesquicillin A is an insecticidal antibiotic derived from a fungal metabolite extracted from Trichoderma albicans. |
|
V54096 | Sitamaquine tosylate (WR 6026 tosylate) | 1019640-33-5 | Sitamaquine (WR 6026) tosylate is an orally bioactive 8-aminoquinoline analogue and antileishmanial active molecule. |
|
V54088 | SJ000025081 | 421571-66-6 | SJ000025081 is a dihydropyridine that could be utilized as an antimalarial agent. |
|
V54076 | SpdSyn binder-1 | 251106-30-6 | SpdSyn binder-1 is a weak binder that binds to the active site of Plasmodium falciparum spermidine synthase. |
|
V54128 | Sporogen AO-1 | 88418-12-6 | Sporogen AO-1 is a fungal metabolite originally extracted from the fungus Aspergillus oryzae. |
|
V5129 | SQ109 (NSC 722041) | 502487-67-4 | SQ109(NSC-722041) is an antituberculosis drug which is currently in advanced clinical trials for the treatment of drug-susceptible and drug-resistant tuberculosis, it is a novel, potent and selective inhibitor of the trypomastigote form of the parasite with IC50for cell killing of 50±8 nM. |
|
V52913 | Strictosamide | 23141-25-5 | Strictosamide plays important roles in inflammation and inflammatory pain. |
|
V15370 | Stylopine | 7461-02-1 | Stylopine [(±)-Stylopine; Tetrahydrocoptisine;(R,S±)-Stylopine;NSC-110382; NSC-404529] is a naturally occurringisoquinolinealkaloid isolated from C. |
|
V35247 | Sulfadoxine-d3 (Sulphadoxine d3) | 1262770-70-6 | Sulfadoxine-d3 is the deuterated form of Sulfadoxine . |
|
V54146 | Sutidiazine (ZY-19489; MMV 253; AZ13721412) | 1821293-40-6 | Sutidiazine (ZY-19489) is an orally bioactive antimalarial agent. |
|
V25152 | T.cruzi Inhibitor (INVIVO1088 HCI) | 1350920-22-7 | T.cruzi-IN-1 is a potent inhibitor of Trypanosoma cruzi with IC50 of 8 nM. |
|
V3882 | Tafenoquine | 106635-80-7 | Tafenoquine (formerly known as SB252263-AAB;WR-238605; WR238605;Brand name Krintafel) is an 8-aminoquinoline analog and oral drug developed by GlaxoSmithKline that has been investigated and approved in 2018 as a potential treatment for malaria, as well as for malaria prevention. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
